Ceftazidime-Avibactam as Osteomyelitis Therapy: A Miniseries and Review of the Literature

Bone and joint infections (BJIs) caused by multidrug-resistant gram-negative bacteria are becoming a concern due to limited therapeutic options. Although not approved for these indications, an ever-growing amount of evidence supports the efficacy and safety of ceftazidime–avibactam as a therapy for...

Descripción completa

Detalles Bibliográficos
Autores principales: Mancuso, Alessandro, Pipitò, Luca, Rubino, Raffaella, Distefano, Salvatore Antonino, Mangione, Donatella, Cascio, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451286/
https://www.ncbi.nlm.nih.gov/pubmed/37627748
http://dx.doi.org/10.3390/antibiotics12081328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451286/
https://www.ncbi.nlm.nih.gov/pubmed/37627748
http://dx.doi.org/10.3390/antibiotics12081328

Ejemplares similares